Chief Technology Officer
Angitia Biopharmaceuticals
Lei Zheng serves as Chief Technology Officer at Angitia Biopharmaceuticals. Angitia Biopharmaceuticals operates in the research sector with approximately 37.0 employees. Angitia Biopharmaceuticals generates annual revenue of 4000000.0. To date, Angitia Biopharmaceuticals has raised 236000000.0 in total funding, with the most recent round being Series C.
Executives like Lei Zheng in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Angitia Biopharmaceuticals.
Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated November 2026.
Lei Zheng's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Technology Officer at Angitia Biopharmaceuticals. Access direct contact info to skip gatekeepers and reach the decision maker.
Lei Zheng is Chief Technology Officer at Angitia Biopharmaceuticals, a company in the research sector with 37.0 employees.
As Chief Technology Officer at Angitia Biopharmaceuticals, Lei Zheng is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Lei Zheng directly — ideal for B2B sales, partnerships, and executive recruiting.
Lei Zheng works in the research industry as Chief Technology Officer at Angitia Biopharmaceuticals. MessageCEO provides verified contact information for executives across all major industries.
Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Lei Zheng's profile is kept up-to-date with the latest available information.